Cite

HARVARD Citation

    Wu, J. et al. (n.d.). ACTR-62. PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE ASTROCYTOMA IN ADULTS. Neuro-oncology. pp. vi27-vi28. [Online]. 
  
Back to record